Comment Re:Choosing the correct tactics (Score 1) 491
Pfizer has simply made exclusivity agreements that pharmacies would not sell generic versions of atorvastatin. This might be bad for the consumer (price-wise, not health-wise), but they can always go to a different pharmacy if theirs refuses to sell the generic.
This is totally incorrect. The pharmacist does no such thing (i'm a pharmacist). Going to a different pharmacy won't do anything.
It's the pharmacy benefit manager that determines this (PBM). The PBM contracts with health plans to manage the pharmacy benefit of a plan. These guys eg Medco, Express-Scripts create exclusive agreements with manufacturers that will force patients to use a brand name when a generic is available because Pfizer is giving a rebate to the PBM. It's two monopolies working together to stick it to the consumer and health plan. Where does that rebate go? In the pockets of the PBM and Pfizer. It's disgusting